Ticker Scorecard - IOVA Basics Company: Iovance Biotherapeutics, Inc. IPO Date: October 23, 2013 Sector: Healthcare Industry: Biotech Market Cap: $2.28B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.10% Avg Daily Range (30 D): $0.21 | 2.81% Avg Daily Range (90 D): $0.25 | 2.81% Institutional Daily Volume Avg Daily Volume: 2.7M Avg Daily Volume (30 D): 6.44M Avg Daily Volume (90 D): 5.89M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 166 Institutional Trades Total Inst.Trades: 5,028 Avg Inst. Trade: $2.58M Avg Inst. Trade (30 D): $3.08M Avg Inst. Trade (90 D): $3.37M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.2M Avg Closing Trade (30 D): $5.28M Avg Closing Trade (90 D): $5.06M Avg Closing Volume: 332.62K     News Jan 17, 2025 @ 10:00 PM Iovance Biotherapeutics Reports Inducement Grants ... Source: N/A Jan 9, 2025 @ 9:52 AM Immunotoxins Market Trends and Regional Business O... Source: Researchandmarkets.Com Dec 20, 2024 @ 10:00 PM Iovance Biotherapeutics Reports Inducement Grants ... Source: N/A Dec 17, 2024 @ 10:29 AM 2 Growth Stocks That Could Rocket Higher in 2025: ... Source: The Motley Fool Dec 12, 2024 @ 3:00 PM Prediction: This Stock Will Beat the Market in 202... Source: Prosper Junior Bakiny Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.48 $-.28 $-.34 Diluted EPS $-1.48 $-.28 $-.34 Revenue $ 90.86M $ 58.56M $ 31.11M Gross Profit $ 8.04M $ 18.73M $ -.26M Net Income / Loss $ -410M $ -83.54M $ -97.1M Operating Income / Loss $ -429.96M $ -89.07M $ -101.91M Cost of Revenue $ 82.82M $ 39.82M $ 31.37M Net Cash Flow $ -163.61M $ -64.57M $ 94.49M PE Ratio     Splits Sep 26, 2013:   100:1 Apr 06, 2010:   1:24